Marcello Damiani
Director/Board Member at Cellarity Inc.
Profile
Marcello Damiani is currently the Director at Cellarity Inc. and the Chief Digital & Operational Excellence Officer at ModernaTX, Inc. He previously worked as an Independent Non-Executive Director at BenevolentAI SA from 2023 to 2024, as the Chief Information Officer & Senior Vice President at bioMérieux SA from 2009 to 2015, and as the Chief Digital & Operational Excellence Officer at Moderna, Inc. from 2015 to 2022.
Mr. Damiani holds a graduate degree from Université Fédérale Toulouse Midi-Pyrénées, an MBA from Trium Global Emba, and undergraduate and graduate degrees from Institut d'Administration Des Entreprises De Toulouse.
Marcello Damiani active positions
| Companies | Position | Start |
|---|---|---|
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | 2018-12-31 |
Former positions of Marcello Damiani
| Companies | Position | End |
|---|---|---|
| BENEVOLENTAI | Director/Board Member | 2024-05-01 |
| MODERNA, INC. | Corporate Officer/Principal | 2021-12-31 |
| BIOMÉRIEUX | Chief Tech/Sci/R&D Officer | 2014-12-31 |
Training of Marcello Damiani
| Trium Global Emba | Masters Business Admin |
| Institut d'Administration Des Entreprises De Toulouse | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MODERNA, INC. | Health Technology |
| BIOMÉRIEUX | Health Technology |
| BENEVOLENTAI | Health Technology |
| Private companies | 2 |
|---|---|
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Marcello Damiani
